Parkinson's Disease

Evaluating the impact of COVID-19 on patients with movement disorders 2:26
Evaluating the impact of COVID-19 on patients with movement disorders
Susanne Schneider • 21 Sep 2022
How can patients with movement disorders receive adequate care and guidance? 1:34
How can patients with movement disorders receive adequate care and guidance?
Susanne Schneider • 19 Sep 2022
Current guidelines for prescribing exercise to patients with Parkinson’s disease 1:39
Current guidelines for prescribing exercise to patients with Parkinson’s disease
Julie Jones • 17 Sep 2022
Barriers to patients with PD exercising as a form of disease management 1:09
Barriers to patients with PD exercising as a form of disease management
Julie Jones • 17 Sep 2022
The role of deep brain stimulation for atypical parkinsonism 1:14
The role of deep brain stimulation for atypical parkinsonism
Carlo Alberto Artusi • 16 Sep 2022
Tools to monitor motor fluctuations in Parkinson’s disease 0:53
Tools to monitor motor fluctuations in Parkinson’s disease
Per Odin • 17 Oct 2022
Parkinson’s disease modification through c-Abl inhibition 4:55
Parkinson’s disease modification through c-Abl inhibition
Milton Werner • 16 Sep 2022
The role of inflammation in Parkinson’s disease 1:50
The role of inflammation in Parkinson’s disease
Marina Romero-Ramos • 17 Sep 2022
PD-MAS validation to measure medication adherence in Parkinson’s disease 0:53
PD-MAS validation to measure medication adherence in Parkinson’s disease
Michelle Tosin • 23 Sep 2022
Lipidomic approaches identify Parkinson’s disease-specific lipid signatures 2:39
Lipidomic approaches identify Parkinson’s disease-specific lipid signatures
Serge Przedborski • 16 Sep 2022
Emerging neuromodulation techniques in Parkinson’s disease 2:22
Emerging neuromodulation techniques in Parkinson’s disease
Carlo Alberto Artusi • 16 Sep 2022
Focusing on quality of life in Parkinson’s disease 1:04
Focusing on quality of life in Parkinson’s disease
Carlo Alberto Artusi • 16 Sep 2022
Feasibility and acceptability of PDConnect: an exercise program for patients with PD 3:13
Feasibility and acceptability of PDConnect: an exercise program for patients with PD
Julie Jones • 5 Oct 2022
Wearable technology in Parkinson’s disease 1:04
Wearable technology in Parkinson’s disease
Esther Cubo • 15 Sep 2022
Early identification of suboptimal PD control to improve care 0:59
Early identification of suboptimal PD control to improve care
Eric Freire-Alvarez • 15 Sep 2022
fMRI and gait analysis characteristics as biomarkers for alpha-synucleinopathies 2:33
fMRI and gait analysis characteristics as biomarkers for alpha-synucleinopathies
Elisabetta Sarasso • 15 Sep 2022
The content of VJNeurology is intended for healthcare professionals